Země: Velká Británie
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Estradiol
Theramex HQ UK Ltd
G03CA03
Estradiol
100microgram/24hour
Transdermal patch
Transdermal
No Controlled Drug Status
Valid as a prescribable product
BNF: 06040101; GTIN: 5012946314085
- 1 - PACKAGE LEAFLET: INFORMATION FOR THE USER EVOREL ® Estradiol Evorel is a registered trademark READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor or pharmacist • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 5. WHAT IS IN THIS LEAFLET 1. What Evorel is and what it is used for 2. What you need to know before you use Evorel 3. Safety of HRT 4. How to use Evorel 5. Possible side effects 6. How to store Evorel 7. Contents of the pack and other information 1. WHAT EVOREL IS AND WHAT IT IS USED FOR The name of your medicine is Evorel. It belongs to a group of medicines called hormone replacement therapy (HRT). Evorel contains an oestrogen (estradiol) which is a female hormone. It comes in 4 different sizes: Evorel 25, Evorel 50, Evorel 75 and Evorel 100. Evorel comes in a ‘memory pack’. This can be used to help you remember when to change your patches. Each pack contains eight patches. Evorel 50 also comes in packs of two and twenty-four patches. The hormone is spread evenly in each patch. It passes slowly into your body through the skin. EVOREL IS USED FOR • The symptoms of the menopause (see ‘What is the menopause?’) EVOREL 50, 75 AND 100 CAN ALSO BE USED TO • Prevent osteoporosis (fragile bones) in women who have had the menopause and are most likely to have bone problems. Evorel 50, 75 and 100 are only used if other medicines for osteoporosis have been tried first and they have not worked. - 2 - WHAT IS THE MENOPAUSE? Women produce oestrogen hormones from their ovaries throughout their adult life. These hormones are important in sexual development and control of the menstrua Přečtěte si celý dokument
OBJECT 1 EVOREL 100 PATCHES Summary of Product Characteristics Updated 16-Dec-2020 | Theramex UK Limited • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Evorel 25 Patch, Evorel 50 Patch, Evorel 75 Patch and Evorel 100 Patch. 2. Qualitative and quantitative composition • Evorel 25: • Evorel 50: • Evorel 75: • Evorel 100: 1.6 mg estradiol/patch 3.2 mg estradiol/patch 4.8 mg estradiol/patch 6.4 mg estradiol/patch 3. Pharmaceutical form Evorel is a square shaped, transparent, self-adhesive transdermal delivery system (patch) of 0.2 mm thickness for application to the skin surface. It consists of a monolayered adhesive matrix throughout which 17β estradiol is uniformly distributed. The adhesive matrix is protected on the outside surface (from clothes etc) by a polyethylene teraphthalate backing foil, while the adhesive surface of the patch is covered by a polyester sheet (the release liner) which is removed before placing the patch on the body surface. This release liner has an Přečtěte si celý dokument